Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
1,182
-
Total 13F shares, excl. options
-
92,595,818
-
Shares change
-
+39,106
-
Total reported value, excl. options
-
$76,020,982,589
-
Value change
-
+$89,011,870
-
Put/Call ratio
-
110%
-
Number of buys
-
550
-
Number of sells
-
-498
-
Price
-
$821.67
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2023
1,326 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2023.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92,595,818 shares
of 104,986,330 outstanding shares and own 88% of the company stock.
Largest 10 shareholders include FMR LLC (9,440,096 shares), BlackRock Inc. (9,418,300 shares), VANGUARD GROUP INC (8,852,121 shares), JPMORGAN CHASE & CO (6,344,151 shares), Capital World Investors (5,830,586 shares), STATE STREET CORP (4,893,616 shares), Dodge & Cox (2,384,701 shares), GEODE CAPITAL MANAGEMENT, LLC (2,217,993 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,178,232 shares), and Capital International Investors (2,153,472 shares).
This table shows the top 1,182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.